Olon Group Increases Capacity at Site in Mulazzano

Olon Group, in partnership with Aguettant Pharmarmaceutical, is expanding and renovating its plant located on Olon’s Mulazzano, Italy site, which is dedicated to the production by enzymatic transformation. The improvement of the plant will boost the site’s reaction capacity and include the installation of several pieces of new equipment including reactors, filters, a refrigerator and a revamping raw material device. During the process, many steps performed by the site will be automatized and digitalized.
 
The new line will be dedicated to the production of phosphorylated sugar. This specific phosphorylated sugar is an important carbohydrate intermediate in glucose metabolism and storage, used to produce an essential injectable treatment. In response to hormonal or neural signals, glycogenolysis occurs in liver and muscle tissues where phosphorylated sugar is released as the rate-limiting step in glycogen breakdown.
 
Mulazzano has been developing the know-how of this sustainable process using renewable raw materials and reagents for many years.
 
“We are proud to collaborate on this expansion, offering our expertise and know-how of this production process, in order to give a broader access to such a fundamental treatment,” said Paolo Tubertini, CEO of Olon Group.